Skip to main content

and
  1. Article

    Open Access

    Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B

    The long-term goal of chronic hepatitis B (CHB) treatment is improvement of liver disease and prevention of cirrhosis. The aim of this study was to assess whether prolonged telbivudine treatment improves liver...

    **-Lin Hou, Daozheng Xu, Guangfeng Shi, Mobin Wan, Zachary Goodman in Advances in Therapy (2015)

  2. No Access

    Article

    Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study

    Fetuin is an endogenous inhibitor of the insulin receptor tyrosine kinase. Recent studies supported the possible role of fetuin B in metabolic diseases. This study is to evaluate the role of serum fetuin B in...

    **zhou Zhu, **ngyong Wan, Yuming Wang, Kefu Zhu, Chunxiao Li, Chaohui Yu in Endocrine (2017)

  3. No Access

    Article

    Increased serum levels of fetuin B in patients with coronary artery disease

    Recent evidence indicates a pivotal role for fetuin B, one of the cystatin superfamily of cysteine protease inhibitors, in the pathogenesis of metabolic diseases. This study investigated whether serum fetuin B...

    Kefu Zhu, Yuming Wang, Pengqin Shu, Qinyi Zhou, **zhou Zhu, Wen**g Zhou in Endocrine (2017)